Successful Treatment with Upadacitinib in Concurrent Atopic Dermatitis, Crohn's Disease, Alopecia Areata, and Eosinophilic Gastropathy in a Pediatric Patient
January 2026
in “
Dermatology Reports
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This case study reports that a 15-year-old male with multiple autoimmune conditions showed significant improvement in skin and gastrointestinal symptoms, along with hair regrowth, after 16 weeks of treatment with the JAK-1 inhibitor upadacitinib, demonstrating its potential in managing complex autoimmune disorders. Our plain-language summary of this paper — not a Tressless recommendation.
A 15-year-old male with atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastroenteropathy showed significant improvement in symptoms and hair regrowth after 16 weeks of treatment with upadacitinib, a JAK-1 inhibitor. This case underscores the potential of JAK inhibitors in treating complex autoimmune disorders with shared pathogenic pathways.
